Study Protocol for Hwangryunhaedoktang in Atopic Dermatitis
Author Information
Author(s): Kim Nam-Kwen, Lee Dong-Hyo, Seo Hyung-Sik, Sun Seung-Ho, Oh Yong-Leol, Kim Ji-Eun, Yoon In-Hwan, Seo Eun-Sung, Shim Gye-Seon, Zaslawski Christopher
Primary Institution: Wonkwang University Oriental Medical Center
Hypothesis
This study aims to establish the clinical efficacy and safety of Hwangryunhaedoktang in adult patients with Atopic Dermatitis.
Conclusion
The trial will provide evidence for the clinical efficacy and safety of Hwangryunhaedoktang in treating Atopic Dermatitis.
Supporting Evidence
- Atopic Dermatitis is a chronic skin disease that significantly impacts quality of life.
- Hwangryunhaedoktang is a widely used herbal medicine in Korea for treating Atopic Dermatitis.
- The study aims to provide high-quality evidence for the efficacy of Hwangryunhaedoktang.
Takeaway
This study is testing a herbal medicine called Hwangryunhaedoktang to see if it helps people with a skin condition called Atopic Dermatitis.
Methodology
A randomised, double-blind, placebo-controlled, two-centre trial with two parallel arms (Hwangryunhaedoktang and a placebo) over 11 weeks.
Potential Biases
Participants may have prior experience with Hwangryunhaedoktang, which could affect their responses.
Limitations
The study may face challenges in participant blinding and potential biases due to prior experiences with the herbal treatment.
Participant Demographics
Adults aged 19 years or older with Atopic Dermatitis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website